SuperworthenVVeno Medical shares outstanding NVNO
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 671K
- On a year earlier
- +15.5%
- more shares
enVVeno Medical had 671K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 15.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 618K | +6% |
| FY2024 | 581.6K | +32% |
| FY2023 | 442.2K | +38% |
| FY2022 | 320.9K | +1% |
| FY2021 | 319.2K | +431% |
| FY2020 | 60.1K | +193% |
| FY2019 | 20.5K | +53% |
| FY2018 | 13.4K | +91% |
| FY2017 | 7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 671K | +15% | |
| Q1 FY26 | 654K | +13% | |
| Q4 FY25 | 618K | +6% | |
| Q3 FY25 | 575.9K | +25% | |
| Q2 FY25 | 581K | +27% | |
| Q1 FY25 | 581K | +27% | |
| Q4 FY24 | 581.6K | +32% | |
| Q3 FY24 | 459.1K | +43% | |
| Q2 FY24 | 459.1K | +43% | |
| Q1 FY24 | 458.8K | +43% | |
| Q4 FY23 | 442.2K | +38% | |
| Q3 FY23 | 320.9K | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on enVVeno Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.